Difference between revisions of "Template:Chemotherapeutic agents"

From blackwiki
Jump to navigation Jump to search
imported>Whywhenwhohow
(add Padeliporfin)
(added entry)
 
(2 intermediate revisions by one other user not shown)
Line 12: Line 12:
 
* ''[[Catharanthus#Vinca alkaloids|Vinca alkaloid]]s'' ([[Vinblastine]]<sup>#</sup>
 
* ''[[Catharanthus#Vinca alkaloids|Vinca alkaloid]]s'' ([[Vinblastine]]<sup>#</sup>
 
* [[Vincristine]]<sup>#</sup>
 
* [[Vincristine]]<sup>#</sup>
 +
* [[Vindesine]]
 
* [[Vinflunine]]<sup>§</sup>
 
* [[Vinflunine]]<sup>§</sup>
* [[Vindesine]]
 
 
* [[Vinorelbine]]<sup>#</sup>)
 
* [[Vinorelbine]]<sup>#</sup>)
  
Line 40: Line 40:
 
* [[Pemetrexed]]
 
* [[Pemetrexed]]
 
* [[Pralatrexate]])
 
* [[Pralatrexate]])
* ''[[Thymidylate synthase inhibitor]]'' ([[Raltitrexed]]
+
* ''[[Thymidylate synthase inhibitor]]'' ([[Pemetrexed]]
* [[Pemetrexed]])
+
* [[Raltitrexed]])
  
 
     | group2 = [[Purine analogue|Purine]]
 
     | group2 = [[Purine analogue|Purine]]
Line 52: Line 52:
 
* [[Nelarabine]]
 
* [[Nelarabine]]
  
* ''[[Thiopurine]]'' ([[Tioguanine]]<sup>#</sup>
+
* ''[[Thiopurine]]'' ([[Mercaptopurine]]<sup>#</sup>
* [[Mercaptopurine]]<sup>#</sup>)
+
* [[Tioguanine]]<sup>#</sup>)
  
 
     | group3 = [[Pyrimidine analogue|Pyrimidine]]
 
     | group3 = [[Pyrimidine analogue|Pyrimidine]]
 
     | list3 =
 
     | list3 =
* ''[[Thymidylate synthase inhibitor]]'' ([[Fluorouracil]]<sup>#</sup>
+
* ''[[Thymidylate synthase inhibitor]]'' ([[Capecitabine]]<sup>#</sup>
* [[Capecitabine]]<sup>#</sup>
+
* [[Carmofur]]
 
* [[Doxifluridine]]
 
* [[Doxifluridine]]
* [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]])
+
* [[Floxuridine]]
* [[Carmofur]]
+
* [[Fluorouracil]]<sup>#</sup>
* [[Floxuridine]])
+
* [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]]))
  
 
* ''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]<sup>#</sup>)
 
* ''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]<sup>#</sup>)
Line 82: Line 82:
 
     | group1 = [[Type I topoisomerase#Inhibition|I]]
 
     | group1 = [[Type I topoisomerase#Inhibition|I]]
 
     | list1 =
 
     | list1 =
* ''[[Camptotheca]]'' ([[Camptothecin]]
+
* ''[[Camptotheca]]'' ([[Belotecan]]
 +
* [[Camptothecin]]
 
* [[Cositecan]]<sup>†</sup>
 
* [[Cositecan]]<sup>†</sup>
* [[Belotecan]]
+
* [[Exatecan]]
 
* [[Gimatecan]]
 
* [[Gimatecan]]
* [[Exatecan]]
 
 
* [[Irinotecan]]<sup>#</sup>
 
* [[Irinotecan]]<sup>#</sup>
 
* [[Lurtotecan]]<sup>‡</sup>
 
* [[Lurtotecan]]<sup>‡</sup>
 +
* [[Rubitecan]]<sup>‡</sup>
 
* [[Silatecan]]<sup>§</sup>
 
* [[Silatecan]]<sup>§</sup>
* [[Topotecan]]
+
* [[Topotecan]])
* [[Rubitecan]]<sup>‡</sup>)
 
  
 
     | group2 = [[Type II topoisomerase#Inhibition|II]]
 
     | group2 = [[Type II topoisomerase#Inhibition|II]]
Line 101: Line 101:
 
     | list3 =
 
     | list3 =
 
* ''[[Anthracycline]]s'' ([[Aclarubicin]]
 
* ''[[Anthracycline]]s'' ([[Aclarubicin]]
 +
* [[Amrubicin]]<sup>†</sup>
 
* [[Daunorubicin]]<sup>#</sup>
 
* [[Daunorubicin]]<sup>#</sup>
 
* [[Doxorubicin]]<sup>#</sup>
 
* [[Doxorubicin]]<sup>#</sup>
 
* [[Epirubicin]]
 
* [[Epirubicin]]
 
* [[Idarubicin]]
 
* [[Idarubicin]]
* [[Amrubicin]]<sup>†</sup>
 
 
* [[Pirarubicin]]
 
* [[Pirarubicin]]
 
* [[Valrubicin]]
 
* [[Valrubicin]]
 
* [[Zorubicin]])
 
* [[Zorubicin]])
 
* ''[[Anthraquinone|Anthracenedione]]s'' ([[Mitoxantrone]]
 
* ''[[Anthraquinone|Anthracenedione]]s'' ([[Mitoxantrone]]
 +
* [[Losoxantrone]]
 
* [[Pixantrone]])
 
* [[Pixantrone]])
  
Line 120: Line 121:
 
     | group1 = [[Alkylating antineoplastic agent|Alkylating]]
 
     | group1 = [[Alkylating antineoplastic agent|Alkylating]]
 
     | list1 =
 
     | list1 =
* ''[[Nitrogen mustard]]s:'' [[Chlormethine]]
+
* ''[[Nitrogen mustard]]s:'' [[Bendamustine]]<sup>#</sup>
 +
* [[Chlormethine]]
 
* [[Cyclophosphamide]]<sup>#</sup> ([[Ifosfamide]]<sup>#</sup>
 
* [[Cyclophosphamide]]<sup>#</sup> ([[Ifosfamide]]<sup>#</sup>
 
* [[Trofosfamide]])
 
* [[Trofosfamide]])
 
* [[Chlorambucil]]<sup>#</sup> ([[Melphalan]]
 
* [[Chlorambucil]]<sup>#</sup> ([[Melphalan]]
 
* [[Prednimustine]])
 
* [[Prednimustine]])
* [[Bendamustine]]<sup>#</sup>
 
 
* [[Uramustine]]
 
* [[Uramustine]]
  
 
* ''[[Nitrosourea]]s:'' [[Carmustine]]
 
* ''[[Nitrosourea]]s:'' [[Carmustine]]
 +
* [[Fotemustine]]
 
* [[Lomustine]] ([[Semustine]])
 
* [[Lomustine]] ([[Semustine]])
* [[Fotemustine]]
 
 
* [[Nimustine]]
 
* [[Nimustine]]
 
* [[Ranimustine]]
 
* [[Ranimustine]]
Line 154: Line 155:
 
     | group3 = [[Alkylating antineoplastic agent#Nonclassical|Nonclassical]]
 
     | group3 = [[Alkylating antineoplastic agent#Nonclassical|Nonclassical]]
 
     | list3 =
 
     | list3 =
 +
* [[Altretamine]]
 
* ''[[Hydrazine]]s'' ([[Procarbazine]]<sup>#</sup>)
 
* ''[[Hydrazine]]s'' ([[Procarbazine]]<sup>#</sup>)
 +
* [[Mitobronitol]]
 +
* [[Pipobroman]]
 
* ''[[Triazene]]s'' ([[Dacarbazine]]<sup>#</sup>
 
* ''[[Triazene]]s'' ([[Dacarbazine]]<sup>#</sup>
 
* [[Temozolomide]])
 
* [[Temozolomide]])
* [[Altretamine]]
 
* [[Mitobronitol]]
 
* [[Pipobroman]]
 
  
 
     | group4 = [[Intercalation (biochemistry)|Intercalation]]
 
     | group4 = [[Intercalation (biochemistry)|Intercalation]]
Line 197: Line 198:
 
** [[Bortezomib]]
 
** [[Bortezomib]]
 
** [[Carfilzomib]]
 
** [[Carfilzomib]]
 +
** [[Oprozomib]]
 
** [[Ixazomib]]
 
** [[Ixazomib]]
 
* ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]])
 
* ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]])
Line 220: Line 222:
 
   | list3 =
 
   | list3 =
 
* [[Amsacrine]]
 
* [[Amsacrine]]
* [[Trabectedin]]
 
* ''[[Retinoid]]s'' ([[Alitretinoin]]
 
* [[Tretinoin]]<sup>#</sup>)
 
 
* [[Arsenic trioxide]]
 
* [[Arsenic trioxide]]
 
* ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]<sup>#</sup>/[[Pegaspargase]])
 
* ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]<sup>#</sup>/[[Pegaspargase]])
Line 229: Line 228:
 
* [[Elesclomol]]<sup>§</sup>
 
* [[Elesclomol]]<sup>§</sup>
 
* [[Elsamitrucin]]
 
* [[Elsamitrucin]]
 +
* [[Eribulin]]
 
* [[Estramustine phosphate]]
 
* [[Estramustine phosphate]]
 
* [[Etoglucid]]
 
* [[Etoglucid]]
Line 237: Line 237:
 
* [[Oblimersen]]<sup>†</sup>
 
* [[Oblimersen]]<sup>†</sup>
 
* [[Omacetaxine mepesuccinate]]
 
* [[Omacetaxine mepesuccinate]]
* [[Eribulin]]
+
* [[Trabectedin]]
 +
* ''[[Retinoid]]s'' ([[Alitretinoin]]
 +
* [[Tretinoin]]<sup>#</sup>)
 +
* [[Venetoclax]]
  
 
  }}
 
  }}

Latest revision as of 14:51, 22 October 2020

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Chemotherapeutic agents|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Chemotherapeutic agents|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Chemotherapeutic agents|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.